Impact of the tapentadol therapy in the management of either moderate neuropathic or nociceptive cancer pain
ESA Academy. Koitabashi T. 06/04/18; 220457; 08AP05-1
Toshiya Koitabashi
Toshiya Koitabashi
Login now to access Regular content available to all registered users.

Access to Premium content is currently a membership benefit.


Click here to join ESA or renew your membership.


Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies